- Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial The Lancet
- Groundbreaking study shows PrEP is safe for pregnant women IOL
- Groundbreaking study led by KZN prof gives green light on use of PrEP during pregnancy and lactation IOL
- View Full coverage on Google News
